Application 020460

Type
NDA
Sponsor
ROCHE PALO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CYTOVENEGANCICLOVIRCAPSULE;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002CYTOVENEGANCICLOVIRCAPSULE;ORAL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
41378SUPPL1997-12-12